The impact of cirrhosis on short and long postoperative outcomes after distal pancreatectomy
Benjamin Coinsin,Thibault Durin,Ugo Marchese,Alain Sauvanet,Safi Dokmak,Zineb Cherkaoui,David Fuks,Christophe Laurent,Cloe Magallon,Olivier Turrini,Laurent Sulpice,Fabien Robin,Philippe Bachellier,Piettro Addeo,David Jérémie Birnbaum,Edouard Roussel,Lilian Schwarz,Jean-Marc Regimbeau,Guillaume Piessen,Guido Liddo,Edouard Girard,Émeline Cailliau,Stéphanie Truant,Mehdi El Amrani
DOI: https://doi.org/10.1016/j.surg.2024.03.038
IF: 4.348
2024-05-31
Surgery
Abstract:Background The impact of cirrhosis on the postoperative outcomes of distal pancreatectomy is yet to be reported. We aimed to evaluate the outcomes of distal pancreatectomy in patients with cirrhosis. Methods We conducted a retrospective, multicentric study patients with cirrhosis who underwent planned distal pancreatectomy between 2008 and 2020 in French high volume centers. Patients with cirrhosis were matched 1:4 for demographic, surgical, and histologic criteria with patients without cirrhosis. The primary endpoint was severe morbidity (Clavien-Dindo grade ≥III). The secondary endpoints were postoperative complications, specifically related to cirrhosis and pancreatic surgery, and survival for patients with pancreatic adenocarcinoma. Results Overall, 32 patients with cirrhosis were matched with 128 patients without cirrhosis. Most patients (93.5%) had Child-Pugh A cirrhosis. The severe morbidity rate after distal pancreatectomy was higher in patients with cirrhosis than in those without cirrhosis (28.13% vs 25.75%, P = .11. The operative time was significantly longer in the cirrhotic group compared with controls ( P = .01). However, patients with and without cirrhosis had comparable blood loss and conversion rates. Postoperatively, the two groups had similar rates of pancreatic fistula, hemorrhage, reoperation, postoperative mortality, and survival rates at 1, 3, and 5 years. Conclusion The current study suggests that distal pancreatectomy in high-volume centers is feasible for patients with compensated cirrhosis.
surgery